PH20568A - Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it - Google Patents
Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising itInfo
- Publication number
- PH20568A PH20568A PH29542A PH29542A PH20568A PH 20568 A PH20568 A PH 20568A PH 29542 A PH29542 A PH 29542A PH 29542 A PH29542 A PH 29542A PH 20568 A PH20568 A PH 20568A
- Authority
- PH
- Philippines
- Prior art keywords
- dietary
- compositions
- pharmaceutical uses
- methyl sulfonylmethane
- methylsulfonylmethane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/418,110 US4514421A (en) | 1979-08-30 | 1982-09-14 | Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
Publications (1)
Publication Number | Publication Date |
---|---|
PH20568A true PH20568A (en) | 1987-02-18 |
Family
ID=23656756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH29542A PH20568A (en) | 1982-09-14 | 1983-09-14 | Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it |
Country Status (13)
Country | Link |
---|---|
US (1) | US4514421A (ru) |
EP (1) | EP0103836B1 (ru) |
JP (1) | JPS59501748A (ru) |
AT (1) | ATE60234T1 (ru) |
AU (2) | AU564536B2 (ru) |
CA (1) | CA1219218A (ru) |
DE (1) | DE3382136D1 (ru) |
DK (1) | DK238384D0 (ru) |
NO (1) | NO841909L (ru) |
NZ (1) | NZ205571A (ru) |
PH (1) | PH20568A (ru) |
SU (1) | SU1443788A3 (ru) |
WO (1) | WO1984001105A1 (ru) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4914135A (en) * | 1979-08-30 | 1990-04-03 | Herschler R J | Use of Methylsulfonylmethane to treat parasitic infections |
US4514421A (en) * | 1979-08-30 | 1985-04-30 | Herschler R J | Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
US4863748A (en) * | 1979-08-30 | 1989-09-05 | Herschler R J | Dietary products and uses comprising methylsulfonylmethane |
US4616039A (en) | 1979-08-30 | 1986-10-07 | Herschler R J | Methylsulfonylmethane in dietary products |
WO1994005293A1 (en) * | 1992-09-04 | 1994-03-17 | Aws Shakir Mustafa Salim | Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol |
GB9218711D0 (en) * | 1992-09-04 | 1992-10-21 | Salim Aws S M | Skin cancer treatment |
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US6902738B2 (en) * | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
US5569679A (en) * | 1994-12-30 | 1996-10-29 | Russell A. Krueger Pharmaceuticals, Inc. | Pharmacologic management of snoring |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
JPH11504939A (ja) * | 1995-05-09 | 1999-05-11 | ザ、プロクター、エンド、ギャンブル、カンパニー | 胃腸障害の治療及び予防用のビスマス含有組成物 |
DE69636254T2 (de) * | 1995-08-24 | 2006-12-14 | Josman Laboratories, Inc., Orange | Bismut enthaltende arzneimittel in topischen darreichungsformen |
US5827543A (en) * | 1995-12-07 | 1998-10-27 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of urogenital disorders |
EP0776665B1 (en) * | 1995-12-07 | 2003-02-19 | The Procter & Gamble Company | Compositons for the prevention and treatment of urogenital disorders, containing bismuth |
US5744168A (en) * | 1995-12-07 | 1998-04-28 | The Procter & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
US5702729A (en) * | 1995-12-07 | 1997-12-30 | The Procter & Gamble Company | Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria |
US6051604A (en) * | 1995-12-07 | 2000-04-18 | The Proctor & Gamble Company | Methods and compositions for the prevention and treatment of gastrointestinal disorders |
CA2239422C (en) * | 1995-12-07 | 2003-03-11 | The Procter & Gamble Company | Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
US7718694B2 (en) * | 1997-10-16 | 2010-05-18 | Children's Hospital & Research Center At Oakland | Compositions and methods for therapy for diseases characterized by defective chloride transport |
US6203820B1 (en) | 1998-05-28 | 2001-03-20 | Brice E. Vickery | Compositions and methods for enhancing protein anabolism and detoxification |
EP1220678B1 (en) * | 1999-10-04 | 2007-03-07 | John Carter | Pharmaceutical compositions containing copper, salicylic acid and vitamin c |
US6787164B2 (en) | 2000-02-23 | 2004-09-07 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6841544B2 (en) * | 2000-02-23 | 2005-01-11 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6793942B2 (en) | 2000-02-23 | 2004-09-21 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6759062B2 (en) | 2000-02-23 | 2004-07-06 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6403116B1 (en) | 2000-11-03 | 2002-06-11 | Triarco Inductries, Inc. | Coenzyme Q10 formulation |
US20040038864A1 (en) * | 2002-06-27 | 2004-02-26 | Per Balschmidt | Use of dimethyl sulfone as isotonicity agent |
US20040029774A1 (en) * | 2002-08-06 | 2004-02-12 | Aly Gamay | Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies |
US20040082667A1 (en) * | 2002-10-16 | 2004-04-29 | Mccadden Kenneth | Hangover treatment |
JP2005298412A (ja) * | 2004-04-13 | 2005-10-27 | Minato Pharmaceutical Co Ltd | 被覆粒子 |
JPWO2005112667A1 (ja) * | 2004-05-20 | 2008-03-27 | 隆史 大森 | 健康食品 |
ITBS20040068A1 (it) * | 2004-05-24 | 2004-08-24 | Gen Topics Srl | Composizione cosmetica e/o farmaceutica per il trattamento della rosacea |
US20060147423A1 (en) * | 2004-12-07 | 2006-07-06 | Jean-Yves Legendre | Transungual device |
US8435224B2 (en) | 2005-09-12 | 2013-05-07 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds |
JP5399072B2 (ja) | 2005-09-12 | 2014-01-29 | アベラ ファーマスーティカルズ インコーポレイテッド | ジメチルスルホキシド(dmso)若しくは関連化合物、又はそれに関連する臭気を除去するシステム |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
EP1937286B1 (en) | 2005-09-12 | 2016-03-09 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
US7754256B2 (en) * | 2007-03-07 | 2010-07-13 | Stan Dennison | Nutritional composition |
BRPI0921494A2 (pt) * | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
EA019538B1 (ru) * | 2009-04-30 | 2014-04-30 | Бактериефритт Ас | Композиция для стерилизации поверхностей |
KR20120093993A (ko) | 2009-10-30 | 2012-08-23 | 아벨라 파마슈티칼스, 인코포레이티드 | 퇴행성 관절염 치료를 위한 디메틸설폭사이드 및 메틸설포닐메탄 제제 |
CA2778142C (en) * | 2009-10-30 | 2018-04-24 | Biogenic Innovations, Llc | Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms |
EP2552200B1 (en) * | 2010-03-31 | 2015-10-14 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) formulations for treating autism |
WO2013150292A1 (en) * | 2012-04-02 | 2013-10-10 | Eaglepharma Pty Ltd | Composition for the treatment of inflammatory and immune disorders |
WO2016010284A1 (ko) * | 2014-07-16 | 2016-01-21 | 유한회사 비엔트리니티 | 울금을 함유한 치약 조성물 및 그 제조 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL26209A (en) * | 1965-08-02 | 1970-10-30 | Merck & Co Inc | Pharmaceutical compositions containing substituted sulphones |
US4333922A (en) * | 1974-09-12 | 1982-06-08 | Herschler R J | Method for the treatment of water-living animals with health modifying agents |
US4514421A (en) * | 1979-08-30 | 1985-04-30 | Herschler R J | Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
US4296130A (en) * | 1979-08-30 | 1981-10-20 | Herschler R J | Methylsulfonylmethane and methods of use |
-
1982
- 1982-09-14 US US06/418,110 patent/US4514421A/en not_active Expired - Lifetime
-
1983
- 1983-09-13 JP JP83503206A patent/JPS59501748A/ja active Pending
- 1983-09-13 WO PCT/US1983/001396 patent/WO1984001105A1/en unknown
- 1983-09-13 EP EP83109006A patent/EP0103836B1/en not_active Expired - Lifetime
- 1983-09-13 AT AT83109006T patent/ATE60234T1/de not_active IP Right Cessation
- 1983-09-13 CA CA000436548A patent/CA1219218A/en not_active Expired
- 1983-09-13 NZ NZ205571A patent/NZ205571A/en unknown
- 1983-09-13 DE DE8383109006T patent/DE3382136D1/de not_active Expired - Lifetime
- 1983-09-13 AU AU20396/83A patent/AU564536B2/en not_active Expired
- 1983-09-14 PH PH29542A patent/PH20568A/en unknown
-
1984
- 1984-05-11 NO NO841909A patent/NO841909L/no unknown
- 1984-05-11 SU SU843745552A patent/SU1443788A3/ru active
- 1984-05-14 DK DK2383/84A patent/DK238384D0/da not_active Application Discontinuation
-
1987
- 1987-06-25 AU AU74732/87A patent/AU599670B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO841909L (no) | 1984-05-11 |
AU7473287A (en) | 1987-10-08 |
EP0103836B1 (en) | 1991-01-23 |
US4514421A (en) | 1985-04-30 |
CA1219218A (en) | 1987-03-17 |
EP0103836A2 (en) | 1984-03-28 |
ATE60234T1 (de) | 1991-02-15 |
NZ205571A (en) | 1986-09-10 |
JPS59501748A (ja) | 1984-10-18 |
AU2039683A (en) | 1984-04-04 |
DK238384A (da) | 1984-05-14 |
AU599670B2 (en) | 1990-07-26 |
DK238384D0 (da) | 1984-05-14 |
EP0103836A3 (en) | 1986-07-30 |
SU1443788A3 (ru) | 1988-12-07 |
WO1984001105A1 (en) | 1984-03-29 |
DE3382136D1 (de) | 1991-02-28 |
AU564536B2 (en) | 1987-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH20568A (en) | Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it | |
DE3680930D1 (de) | Sich schnell verfluessigende kautablette. | |
AU584685B2 (en) | Pharmaceutical and dietary compositions | |
ES2152966T3 (es) | Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion. | |
ATE58471T1 (de) | Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel. | |
CA2303537A1 (en) | Solid oral dosage form comprising a combination of metformin and glibenclamide | |
MY103525A (en) | Pharmaceutical composition comprising cefuroxime axetil | |
OA09023A (fr) | Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. | |
KR840005662A (ko) | 진통캡슐제의 제조방법 | |
JPS6466159A (en) | Vanadyl organic-inorganic compound and manufacture of drug composition containing same | |
US4743596A (en) | Anti-arthritic preparation | |
KR960000217A (ko) | L- 카르니틴염과 이를 함유한 조성물 | |
BE901073A (fr) | Composition antidiuretique a usage oral. | |
CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
KR870002845A (ko) | 식욕조절 및 위암억제용 조성물 | |
US4446132A (en) | Nontoxic aspirin composition | |
ATE15331T1 (de) | Verfahren fuer die orale verabreichung von substanzen in der form von liposomen, und ihre pharmazeutischen zusammensetzungen. | |
JPS55122715A (en) | Antidiabetic agent | |
EP0228239A3 (en) | Preparation of a medicament for arthritis and rheumatism | |
PT84580A (en) | Process for the preparation of pharmaceutical compositions containing indomethacin | |
JPS5498791A (en) | Anti-asthmatic drug | |
JPS59139322A (ja) | 下痢治療剤 | |
DE3171821D1 (en) | Pharmaceutical compositions | |
JPS57167912A (en) | Antitumor agent | |
EP0009046A1 (en) | Composition containing salicylsalicyclic acid and acetaminophen |